Category: Federal Forum Posters
Purpose: Fort Defiance Indian Hospital Board Inc. (FDIHB) currently has two full-time diabetes clinics with fifteen diabetes trained pharmacists. A collaborative practice agreement is in place to provide diabetes education, as well as, medication titration. The purpose of this study is to identify a select group of patients who are both willing and able to use a continual glucose monitor (CGM) in hopes of achieving optimal glycemic control, decreasing HbA1c, and improving overall outcomes for these individuals.
Methods: This pilot project will be completed within the pharmacy run diabetes clinic at FDIHB. Informed consent from all participating subjects will be obtained prior to the commencement of continual glucose monitoring (CGM) therapy. The inclusion criteria consists of: ≥18 years of age, diagnosis of type 1 or type 2 diabetes mellitus, currently on, or agree to, initiate insulin regimen(s), HbA1c ≥ 9.0% drawn in past three months or experience frequent hypoglycemia regardless of HbA1c, an active consult on file to the pharmacy diabetes clinic from a facility provider, and willingness to participate in the study. Patients who meet the inclusion criteria will be enrolled in the six month study. A baseline HbA1c will be drawn, and enrolled patients will undergo two, 14 day periods of CGM during the 6 month study. The pharmacist will download the data from the CGM at each visit, interpret results, adjust medications per protocol, and schedule follow up appointments. As a control, a retrospective analysis will be conducted to evaluate the change in HbA1c six months prior to the implementation of CGM compared to the change in HbA1c collected during the six month trial period.
Results: not applicable
Conclusion: not applicable
Chace Erickson– Pharmacy Resident, Fort Defiance Indian Hospital Board Inc., Fort Defiance, AZ